BCL2 and melanoma: Indeed, the combination of PLX4032 (or GSK1120212) and ABT737 (or ABT263) promoted rapid and robust apoptosis that was defined by BCL-2 family regulated cytochrome c release and caspase activation in naïve melanoma cell lines [6].